STRS Ohio’s Arcus Biosciences RCUS Stock Holding History

STRS Ohio’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.21M	Buy	39,300 +22,500	+134%	+$556K	﹤0.01%	657
2026 Q1	$363K	Hold	16,800	–	–	﹤0.01%	1244
2025 Q4	$400K	Buy	+16,800	New	+$343K	﹤0.01%	1184
2025 Q2	–	Sell	-8,500	Closed	-$66.7K	–	2289
2025 Q1	$66.7K	Hold	8,500	–	–	﹤0.01%	1735
2024 Q4	$127K	Hold	8,500	–	–	﹤0.01%	1600
2024 Q3	$130K	Buy	8,500 +1,600	+23%	+$25.2K	﹤0.01%	1657
2024 Q2	$105K	Buy	+6,900	New	+$111K	﹤0.01%	1693
2024 Q1	–	Sell	-8,300	Closed	-$158K	–	2017
2023 Q4	$158K	Buy	8,300 +5,900	+246%	+$94.3K	﹤0.01%	1624
2023 Q3	$43K	Buy	+2,400	New	+$48.2K	﹤0.01%	1807
2023 Q2	–	Sell	-22,600	Closed	-$412K	–	2070
2023 Q1	$412K	Sell	22,600 -3,500	-13%	-$66.9K	﹤0.01%	1402
2022 Q4	$539K	Sell	26,100 -6,500	-20%	-$179K	﹤0.01%	1282
2022 Q3	$852K	Sell	32,600 -1,700	-5%	-$45K	﹤0.01%	993
2022 Q2	$869K	Buy	+34,300	New	+$840K	﹤0.01%	1005
2021 Q4	–	Sell	-16,400	Closed	-$571K	–	2286
2021 Q3	$571K	Hold	16,400	–	–	﹤0.01%	1459
2021 Q2	$450K	Buy	16,400 +4,500	+38%	+$129K	﹤0.01%	1595
2021 Q1	$334K	Sell	11,900 -6,900	-37%	-$240K	﹤0.01%	1687
2020 Q4	$488K	Buy	18,800 +6,000	+47%	+$145K	﹤0.01%	1485
2020 Q3	$219K	Sell	12,800 -500	-4%	-$11.2K	﹤0.01%	1644
2020 Q2	$329K	Buy	+13,300	New	+$359K	﹤0.01%	1499
2018 Q3	–	Sell	-1,500	Closed	-$19.1K	–	2168
2018 Q2	$18K	Buy	+1,500	New	+$23.5K	﹤0.01%	2062

Other funds holding RCUS

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

STRS Ohio's RCUS Position: Q2 2026 in Review

STRS Ohio increased its Arcus Biosciences (RCUS) stake by 134% in Q2 2026, buying an estimated $556K and bringing the position to 39,300 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #657.

STRS Ohio first reported a position in RCUS in Q2 2018 and has held it in 20 quarters since. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

STRS Ohio held 39,300 shares of Arcus Biosciences worth $1.21M as of Q2 2026.
STRS Ohio bought 22,500 Arcus Biosciences shares in Q2 2026, an estimated $556K.
Arcus Biosciences made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #657 holding.
STRS Ohio first reported a position in Arcus Biosciences in Q2 2018 and has held it in 20 quarters since.
232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.